Medical
Health
Manufacturing
Accuray
$4.649876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.07 (-1.49%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Accuray and other stocks, options, ETFs, and crypto commission-free!
About
Accuray Incorporated Common Stock, also called Accuray, is a radiation oncology company, which engages in the developmen, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Read More Adler in 1990 and is headquartered in Sunnyvale, CA.
Employees
998
Headquarters
Sunnyvale, California
Founded
1990
Market Cap
413.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
746.55K
High Today
$4.73
Low Today
$4.59
Open Price
$4.70
Volume
112.24K
52 Week High
$5.40
52 Week Low
$3.17
Collections
Medical
Health
Manufacturing
Therapy
Technology
News
Simply Wall StMar 21
Are Insiders Selling Accuray Incorporated (NASDAQ:ARAY) Stock?
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we’ll take a look at whether insiders have been buying or selling shares in Accuray Incorporated (NASDAQ:ARAY). What Is Insider Selling? Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock on the market. However, mos...
Price Paid on Robinhood
2% Higher
Right Now
52 Week Low
$3.17
Average Price Paid
$4.53
52 Week High
$5.40
Earnings
-$0.11
-$0.07
-$0.04
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Apr 29, After Hours